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Abstract
Background: In the United States, female breast cancer was the leading cause of new cancer
cases from 2011-2015. Since the Women’s Health and Cancer Act of 1998 (WHCRA), the
federal government mandates employee and private health insurance providers to cover breast
reconstruction if they cover mastectomies. Postmastectomy breast reconstruction (PBR) rates
increased after the WHCRA, but these rates have remained relatively low throughout recent
years. Objective: The objective of this study was to determine factors associated with women
having PBR due to breast cancer in Nevada and the United States from 2008 to 2013. Methods:
Using two HCUP database, NIS and SID databases, this study used complex multiple logistic
regression and binary logistic regression to analyze the association between PBR and specific
demographic, payer type, and hospital characteristics in the United States and Nevada. Weighted
frequencies were calculated for the different breast reconstruction procedures and comorbidities
that this study utilizes. Results: The results demonstrated that women who were younger, nonAfrican American, had private health insurance, were in the high-income status category, and
received care at an urban teaching hospital had higher odds of having PBR than other women. In
Nevada and the United States, surgeons performed tissue expander insertions more than any
other breast reconstruction procedure. The same nine comorbidities were prevalent among
women in the United States and Nevada. Conclusion: Disparities among age, payer types,
racial/ethnic groups, and socioeconomic status in PBR still exist in the United States. Nevada
should consider implementing breast reconstruction education policies to decrease these
disparities and policy makers should ensure that federally mandated education is available in
multiple languages, as well as, representative of all of cultures.
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Introduction
Female breast cancer was the leading cause of new cancer cases from 2011-2015, with an
incidence rate of 124.7 new cases per 100,000 women in the United States. Over the past decade,
breast cancer rates have stayed relatively constant between 121 and 125 new breast cancer cases
per 100,000 females (U.S. Cancer Statistics Working Group, 2018). There was a 36% decrease
in breast cancer death rates in the United States from 1989-2012. This decrease could be related
to better prevention screenings (mammography and MRIs) and advancements in treatment
options (American Cancer Society, 2015).
Mammectomies and mastectomies are the two primary surgical treatments for breast
cancer. A mammectomy is a procedure that removes only the neoplasm (tumor) in the breast. It
is considered a breast-conserving surgery and is also called a partial mastectomy, a lumpectomy,
or a wide local excision (McGuire et al., 2009; American Cancer Society, 2015). A
mammectomy followed by radiation has the same survival rates as a mastectomy for early-stage
breast cancer. For this reason, mammectomy rates have increased in the past twenty years in the
United States for all ages, races, and ethnicities (Hwang, Lichtensztajn, Gomez, Fowble, &
Clarke, 2013). There are two main types of mastectomies, simple and radical. A radical
mastectomy involves removal of the entire breast, areola, nipple, all levels of the axillary lymph
nodes, and both pectoral muscles. Over the years, the radical mastectomy procedure has had
modifications. The main difference is the preservation of pectoral muscles and level III axillary
lymph nodes. Radical mastectomies are not common today; surgeons perform modified radical
mastectomies instead. Another option is a simple mastectomy. This procedure removes breast
tissue, areola, and the nipple. Mastectomies depend on the patients’ stage and type of cancer and
can be performed on one (unilateral) or both breasts (bilateral) (McGuire et al., 2009; Willey &
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Manasseh, 2011). Just like mammectomy rates, mastectomy rates have been increasing.
Hospital-based bilateral mastectomies due to cancer have increased threefold from 10
mastectomies to 29.7 mastectomies per 100,000 women between 2005 to 2013. In that same time
range, inpatient mastectomy (all causes) rates doubled, while outpatient mastectomy (all causes)
rates increased over fivefold (Steiner, Weiss, Barrett, Fingar, & Davis, 2016). The increased
rates of these two surgical treatments have contributed to increased breast reconstruction rate as
well (McGuire et al., 2009).
The Women’s Health and Cancer Rights Act of 1998 (WHCRA) mandated employee and
private health insurance providers to cover breast reconstruction in policies if they cover
mastectomies. Mandates included covering the various stages of breast reconstruction,
reconstruction of the uninflected breast for symmetry, and WHCRA is not limited to
mastectomies due to cancer (Wong-Pan, 2012). State legislation began to pass laws that allowed
Medicaid and Medicare to cover breast reconstruction. From 1998-2008, postmastectomy breast
reconstruction (PBR) rates increased from 20.8% to 37.8% and advancements in breast
reconstruction surgery contributes to increasing rates (Shippee, Kozhimannil, Rowan, & Virnig,
2014). Legislation has helped make reconstruction accessible, as well as, a vital part of breast
cancer treatment for women (Liaw et al., 2013; Butler, Familusi, Serletti, & Fox, 2017).
A patient can either have postmastectomy breast reconstruction (PBR), which involves
having reconstruction at the same time as a mastectomy or delay breast reconstruction (DBR)
until another time. The decision to have PBR or to postpone it can be due to various reasons.
Either patient’s personal preference or receiving radiation may be reasons for them to wait to
have breast reconstruction. Radiation can increase the chances of complications, like flap
necrosis, implant exposure, and problems with tissue expanders (McCue, Miglior, &
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Cunningham, 2010.) Despite these reasons, PBR has gained popularity over the years. From
2005-2012, PBR rates have increased by 50% (Kwok, Goodwin, Ying, & Agarwal, 2014).
Surgeons perform several different types of breast reconstruction today, but this study
will only analyze certain procedures. Breast implants and tissue expanders have been used the
longest for breast reconstruction and are the simplest reconstruction procedures. If there is
enough tissue to cover the implant after a mastectomy, surgeons will insert a breast implant into
a pocket they created under the pectoralis major muscle. If there is not enough tissue after a
mastectomy, tissue expanders are placed into the pocket instead. After the surgery, expanders are
filled with a saline solution over months (up to six months) until the desired size is achieved
(McCue et al., 2010).
Autologous flaps are another breast reconstruction procedure. Surgeons use the patient’s
skin and tissue from another place on their body to reconstruct the breast(s). These flaps will
result in a more natural breast than implants. The latissimus dorsi (LD) flap is a procedure where
surgeons use part of the LD muscle, fat, tissue, and skin to reconstruct the breast(s). Implants, as
well as, tissue expanders can be used with this flap procedure, and blood vessels remain attached
to the original blood supply. (Boehmler & Butler, 2010). Another autologous flap is the
transverse rectus abdominis myocutaneous (TRAM) flap. Surgeons use the rectus abdominis
muscle, along with abdominal fat, skin, and blood vessels to reconstruct the breast(s). There are
two versions of the TRAM flap this study will analyze: pedicle and free. TRAM pedicle is
similar to the LD flap because the blood vessels stay connected to the original blood supply,
while the TRAM free flap involves microsurgery that attaches the blood vessels to a new blood
supply closer to the breast (Weiss, 2010; Liaw et al., 2013). The deep inferior epigastric artery
perforator (DIEP) flap is a free flap procedure that evolved from the TRAM flap. It conserves the
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rectus abdominal muscles and only uses abdominal fat, tissue, and skin to reconstruct the
breast(s). Just like the TRAM flap, the rectus abdominis is dissected to reach the blood vessels
needed for the flap (Lipa, 2010). Another procedure that conserves the rectus abdominal muscles
is the superficial inferior epigastric artery (SIEA) flap. This flap is similar to the DIEP flap, but
the blood vessels needed for the flap are superficial to the rectus abdominal muscles, meaning
those muscles are left undisturbed (Spiegel & Eldor, 2010). The gluteal artery perforator (GAP)
flap is the last breast reconstruction procedure analyzed in this study. This procedure uses gluteal
blood vessels instead of abdominal blood vessels and does not use any muscle in the flap. Two
different arteries can be used, the inferior gluteal artery and the superior gluteal artery. The usage
of either one depends on preferred scar position, distribution of fat, and if sizable blood vessels
can be found. This procedure is usually used as an alternate when other autologous flaps will not
work for the patient (Cheng & Huang, 2010).
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Background and Significance
Mastectomies are an essential part of breast cancer treatment, but this procedure can have
a negative impact on a woman’s social, psychological, and sexual function (Veronesi et al.,
2011; Platt, Baxter, & Zhong, 2011). A literature review reports that out of thirteen papers, most
of them claimed that up to 50% of women reflected a lower body image than before their
mastectomy (McGaughey, 2006). Al-Ghazal and coauthors (2000) concluded that 63% of their
patients who had PBR did not lose their sense of sexual attractiveness, which they believe
corresponds with sexual function. The researchers also suggest that patients who had PBR
showed a lower level of distress than patients that had DBR (Al-Ghazal, Sully, Fallowfield, &
Blamey, 2000). Breast reconstruction has shown to decrease the severity of negative impacts
caused by a mastectomy, so it is essential for physicians to discuss breast reconstruction options
with all patients (Morrow, Scott, Menck, Mustoe, & Winchester, 2001; Reuben, Manwaring, &
Neumayer, 2009; Veronesi et al., 2009; McGuire et al., 2009).
PBR was an unpopular choice for breast cancer treatment historically. Initially, surgeons
questioned whether PBR would affect detection of reoccurring breast cancer (Morrow et al.,
2001; McGuire et al., 2009). Noone and colleagues (1993) reported that when patients had a
reoccurrence of breast cancer, breast reconstruction did not affect detection and PBR did not
increase reoccurrence rates (Noone et al., 1994). With the advancements in breast reconstruction
mentioned already, these procedures do not interfere with detecting breast cancer reoccurrence
(Atisha et al., 2008; Barnsley, Sigurdson, & Kirkland, 2008; Morrow et al., 2001; Reuben et al.,
2009).
Three years after the WHCRA, PBR was recommended as an early-stage breast cancer
treatment by the Commission on Cancer of the American College of Surgeons. After this
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happened, these rates rose (Platt et al., 2011). Yang and colleagues (2012) found that before
policy changes, PBR rates were 18.5% in Pennsylvania, these rates nearly doubled between 2001
and 2004 to 32.7% (Yang et al., 2013). Even though PBR rates increased after policy changes,
they remain relatively constant today (Platt et al., 2011; Reuben et al., 2009; Yang et al., 2013).
Furthermore, several population-based studies found that between 2003 and 2007 only 25% to
35% of women have PBR in the United States (Morrow et al., 2014; Kruper et al., 2011;
Alderman et al., 2009; Reuben et al. 2009). Researchers speculate several factors influence the
breast reconstruction decision-making process, but they know little about the women having
PBR (Morrow et al., 2001; Rueben et al., 2009).
Age is speculated to have a critical role in this decision-making process. It is believed
that older women are not having breast reconstruction as often as younger women because they
have more comorbidities that could affect the surgery (Platt et al., 2011). Despite this belief,
Reuben and colleagues (2009) found that age was a factor for PBR after controlling for
comorbidities (Rueben et al., 2009). The reasons why older women do not have PBR as often as
younger women are still unknown. It could be due to personal preference or not being informed
about their options by their physicians (Lipa, Youssef, Kuerer, Robb, & Chang, 2003).
Race and ethnicity are factors that can potentially influence a woman’s decision to have
PBR. A study that assessed the impact of the WHCRA on PBR rates found that the WHCRA did
not eliminate the racial/ethnic disparities in PBR, even though that was the intent. Minority
women were still less likely than white women to have PBR (Alderman, Wei, & Birkmeyer,
2006). A lack of breast reconstruction education for minorities and cultural differences in the
value of women’s breasts may be associated with these racial/ethnic disparities (Yang et al.,
2013).
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Socioeconomic status (SES) and payer type may potentially influence PBR rates. Barriers
could exist for women with lower SES that don’t exist for women with higher SES regarding
breast reconstruction, including lower education levels, not having a consultation with a
reconstruction surgeon, seeing a physician that is not educated on breast reconstruction, and not
having access to appropriate care (Morrow et al., 2001; Kruper et al., 2011). The influence from
payer type, SES, and race combined may have more of an impact on the breast reconstruction
decision-making process than if they were analyzed individually. More research is needed to
understand the effect these factors have on breast reconstruction (Butler et al., 2018).
The location and type of the hospital a woman goes to can impact the breast
reconstruction decision-making process. Urban hospitals have the ability for larger plastic
surgery departments that can perform more types of breast reconstruction than rural hospitals
can, which could be an advantage for patients (Kruper et al., 2011; Reuben et al., 2009). Along
with urban hospitals, a few studies found that National Cancer Institute (NCI)-Designated
Cancer Centers were 40% more likely to perform PBR than other hospital types (Morrow et al.,
2001; McGuire et al., 2009). Research shows that both NCI-Designated Cancer Centers and
teaching hospitals perform PBR more than nonteaching hospitals (Kruper et al., 2011; Reuben et
al., 2009; Platt et al., 2011).
Significance and Objective
In a literature search for published studies on PBR, there were no studies to our
knowledge specific to Nevada. State-specific data are needed to identify the populations having
PBR in each state. Furthermore, Reuben et al. (2009) concluded that the published national data
on PBR is outdated. The objective of this study is to determine factors associated with women
having PBR due to breast cancer in Nevada and the United States from 2008 to 2013.
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Research Questions
1. Which demographic variables are associated with PBR due to breast cancer in Nevada
and the United States?
▪

H0= There are no demographic variables associated with PBR due to breast cancer
in Nevada and the United States.

▪

HA= There are demographic variables associated with PBR due to breast cancer in
Nevada and the United States.

2. Does the location and the teaching status of the hospital affect whether a woman has PBR
due to breast cancer in the United States?
▪

H0= There is no difference in the location and teaching status of hospitals with
women who had PBR compared to women who did not have breast reconstruction
after a mastectomy due to breast cancer in the United States.

▪

HA= There is a difference in the location and teaching status of hospitals with
women who had PBR compared to women who did not have breast reconstruction
after a mastectomy due to breast cancer in the United States.

3. Does payer type affect whether a woman has PBR due to breast cancer in the United
States and Nevada?
▪

H0= There is no difference in payer types with women who had PBR compared to
women who did not have breast reconstruction after a mastectomy due to breast
cancer in the United States and Nevada.

▪

HA= There is a difference in payer types with women who had PBR compared to
women who did not have breast reconstruction after a mastectomy due to breast
cancer in the United States and Nevada.
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4. Are there certain types of breast reconstruction performed more frequently during PBR
due to breast cancer in Nevada and the United States?
▪

H0= There is no difference in the types of breast reconstruction performed during
PBR due to breast cancer in Nevada and the United States.

▪

HA= There is a difference in the types of breast reconstruction performed during
PBR due to breast cancer in Nevada and the United States.

5. Are there comorbidities that are more prevalent with PBR due to breast cancer in Nevada
and the United States?
▪

H0= There are no differences in the prevalence of comorbidities between those
with and without having breast reconstruction after a mastectomy due to breast
cancer in Nevada and the United States.

▪

HA= There are differences in the prevalence of comorbidities between those with
and without having breast reconstruction after a mastectomy due to breast cancer
in Nevada and the United States.
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Methodology
Databases
This study is a secondary analysis utilizing two Healthcare Cost and Utilization Project
(HCUP) databases. The HCUP databases are a collection of several healthcare databases
supported by the Agency for Healthcare Research and Quality (AHRQ). In the United States, this
database contains a vast amount of longitudinal data on hospital care, including “all-payer” data.
HCUP was initiated in 1988 and was designed to improve hospital care by providing a potent
source of national, state, and “all-payer” information for organizations to use (Healthcare Cost
and Utilization Project [HCUP], 2018[a]). It is important to note HCUP uses discharge record as
the unit, not individual patients (HCUP, 2018[c]).
The National (Nationwide) Inpatient Sample (NIS) is an HCUP database that contains
data on inpatient care in the United States. The NIS database represents approximately 97% of
US hospital discharges (only short-term, non-Federal hospitals) regardless of the payer type,
resulting in an available sample of several million discharge records per year (HCUP, 2018[b]).
In 2012, the NIS database changed from the Nationwide Inpatient Sample to the National
Inpatient Sample. The name change was due to improvements made to the database, the most
crucial being sample design. The new NIS database receives discharge records from all HCUP
hospitals rather than from a sample of hospitals. All changes were made to reduce sampling error
and more precise estimates (HCUP, 2018[c]).
The State Inpatient Databases (SID) contain all inpatient records (clinical and nonclinical
information) for states that choose to participate. It differs from the NIS database because the
NIS database is a sample of discharge records in the United States, while the SID databases
include discharge records from states that participate. The SID databases are essential for
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obtaining estimates for individual states since the NIS database was not designed for such
analyses (HCUP, 2018[c]).
Study Population
The NIS and the SID databases were used to identify discharge records of female breast
cancer patients between the ages of 18 and 90 years who had a mastectomy between 2008 and
2013 in both Nevada and the United States. Participant’s breast cancer diagnosis and mastectomy
type were determined based on the International Classification of Diseases, ninth revision (ICD9) (Table 1 & Table 2).

Table 1. ICD-9 Diagnosis Codes for Breast Cancer
Code

Procedure
174

Malignant neoplasm nipple

174.1

Malignant neoplasm breast-central

174.2

Malignant neoplasm breast up-inner

174.3

Malignant neoplasm breast low-inner

174.4

Malignant neoplasm breast up-outer

174.5
174.6

Malignant neoplasm breast low-outer
Malignant neoplasm breast-axillary

174.8

Malignant neoplasm breast NEC (Malignant neoplasm of other specified sites of female breast)

174.9
233

Malignant Neoplasm Breast NOS (Malignant Neoplasm of breast (female) unspecified)
Carcinoma in situ of breast

238.3

Neoplasm of uncertain behavior of breast

239.3

Neoplasm of unspecified nature of breast
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Table 2. ICD-9 Procedure Codes for Mastectomy
Code

Procedure
85.33

Unilateral subcutaneous mammectomy with synchronous implant

85.34
85.35
85.36
85.4

Other unilateral subcutaneous mammectomy
Bilateral subcutaneous mammectomy with synchronous implant
Other bilateral subcutaneous mammectomy
Mastectomy

85.41

Unilateral simple mastectomy

85.42

Bilateral simple mastectomy

85.43

Unilateral extended simple mastectomy

85.44

Bilateral extended simple mastectomy

85.45

Unilateral radical mastectomy

85.46

Bilateral radical mastectomy

85.47

Unilateral extended radical mastectomy

85.48

Bilateral extended radical mastectomy

Variables
The dependent variable derived from the data represented breast reconstruction status
(RECON). RECON was determined by eleven different ICD-9 breast reconstruction procedure
codes (Table 3). It is a dichotomous variable with 1= having breast reconstruction and 0= not
having breast reconstruction. In this study, twenty-nine comorbidity variables were used to create
a comorbidity indicator variable that was used as a covariate in the multiple logistic regression
models (SUMCMBS; Table 4). SUMCMBS is the sum of the twenty-nine variables, and it is
continuous.
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Table 3. ICD-9 Procedures Codes that Create RECON
Code
85.53

Procedure
Unilateral breast implant

85.54

Bilateral breast implant

85.95

Insertion of breast tissue expander

85.71

Latissimus dorsi myocutaneous flap

85.72

Transverse rectus abdominis myocutaneous flap, pedicled

85.73

Transverse rectus abdominis myocutaneous flap, free

85.74

Deep inferior epigastric artery perforator (DIEP) flap, free

85.75

Superficial inferior epigastric artery (SIEA) flap, free

85.76
85.7

Gluteal artery perforator (GAP) flap, free
Total Reconstruction of Breast

85.79

Other total reconstruction of breast

Table 4. List of Comorbidities that Creates SUMCMBS
Variable Name
CM_AIDS
CM_ALCOHOL
CM_ANEMDEF

Description
Acquired immune deficiency syndrome
Alcohol abuse
Deficiency anemias

CM_ARTH
CM_BLDLOSS
CM_CHF
CM_CHRNLUNG
CM_COAG
CM_DEPRESS
CM_DM

Rheumatoid arthritis/collagen vascular diseases
Chronic blood loss anemia
Congestive heart failure
Chronic pulmonary disease
Coagulopathy
Depression
Diabetes

CM_DMCX
CM_DRUG
CM_HTN_C
CM_HYPOTHY
CM_LIVER
CM_LYMPH
CM_LYTES
CM_METS
CM_NEURO
CM_OBESE
CM_PARA
CM_PERIVASC
CM_PSYCH
CM_PULMCIRC
CM_RENLFAIL
CM_TUMOR
CM_ULCER
CM_VALVE
CM_WGHTLOSS

Diabetes with chronic complications
Drug abuse
Hypertension (combine uncomplicated and complicated)
Hypothyroidism
Liver disease
Lymphoma
Fluid and electrolyte disorders
Metastatic cancer
Other neurological disorders
Obesity
Paralysis
Peripheral vascular disorders
Psychoses
Pulmonary circulation disorders
Renal failure
Solid tumor without metastasis
Peptic ulcer disease excluding bleeding
Valvular disease
Weight loss
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Several purportedly important predictors were utilized for modeling. Four out the five
independent variables were categorical in this study. The HCUP databases were obtained
initially with categorized variables. In the SID database, age (AGE1) was separated into three
groups; 18-40 years old, 41-64 years old, and 65-90 years old, while in the NIS data models, age
(AGE1) was grouped by decades except for two groups; 18-29 years old and 80-90 years old.
Payer type (PAYERTYPE) was categorized into six different categories for both databases; 1=
Other 2= No charge 3= Medicare 4= Medicaid 5= Self-pay 6= Private insurance. In the NIS
database, the private insurance category included private HMOs and PPOs, commercial carriers,
and Blue Cross. The other category was defined as government programs including Worker’s
Compensation, CHAMPUS (TRICARE) and CHAMPVA, and Title V. CHAMPVA and
TRICARE are two military healthcare programs that serve active duty members and retired
members, their families, and veterans (Benefits.gov, n.d). Title V is a federal grant program
focused on providing a wide variety of health care to mothers and children with barriers to
quality health care (Health Resources & Services Administration [HRSA], 2019). In the SID
database, Worker’s Compensation was included in the private health insurance category until
2012 where it was moved to the other category (HCUP, 2018[d]). Race (RACE1) was grouped
into six categories for the NIS database; 1= Other 2= Native American 3= Asian or Pacific
Islander 4= Hispanic 5= White, 6= African American. For the SID database though, race
(RACE1) was categorized into two groups; white and nonwhite. Median household income for
patient’s zip code (ZIPINC_QRTL) was grouped into quartiles based on median income by year
(Table 5); 1= 0-25th percentile (low-income) 2= 26th-50th percentile (low/middle-income) 3= 51st75th percentile (high/middle-income) 4= 76th-100th percentile (high-income). The variable for
hospital location and teaching status (HOSP_LOCTEACH) had three categories; 1= Rural 2=
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Urban nonteaching 3= Urban teaching. This variable combines hospital location and teaching
status into one variable. The individual variables for location (HOSP_LOCATION) and teaching
status (HOSP_TEACH) were discontinued in 2011 and thus were not used in this study. The SID
database, however, does not include variables to analyze hospital location or hospital teaching
status, and therefore the state-based models will not contain HOSP_LOCTEACH (HCUP,
2018[d]).

Table 5. Quartile Ranges for ZIPINC_QRTL by Year
Year

Quartile 1

Quartile 2

Quartile 3

Quartile 4

2008

1 - 38,999

39,000 - 48,999

49,000 - 63,999

64,000+

2009

1 - 39,999

40,000 - 49,999

50,000 - 65,999

66,000+

2010

1 - 40,999

41,000 - 50,999

51,000 - 66,999

67,000+

2011

1 - 38,999

39,000 - 47,999

48,000 - 63,999

64,000+

2012

1 - 38,999

39,000 - 47,999

48,000 - 62,999

63,000+

2013

1 - 37,999

38,000 - 47,999

48,000 - 63,999

64,000+

Data Preparation
The NIS and SID databases includes many diagnosis and procedure codes, making these
databases extensive and complex (HCUP, 2018[a]). A solution to this complexity was to remove
all discharge records that did not include any of the twelve breast cancer codes listed in Table 1
and any of the thirteen mastectomy codes in Table 2 from the two databases. The removal of
these discharge records resulted in the final dataset that was utilized for analyses. In addition,
discharge records for women who were not between the ages of 18 and 90 years old were
removed from both databases as well.
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When reviewing these datasets, the discharge records showed some women having
multiple breast reconstruction procedures during the same surgery. This study was concerned
with whether a woman did or did not have breast reconstruction and not with the total quantity of
breast reconstruction procedures they had. The RECON variable was created to accommodate
this. There were fifteen procedure variables (PR1-15) in the NIS database and twenty-five in the
SID database. These procedure variables were recoded into RECON1-15 for the NIS database
and RECON1-25 for the SID database. RECON1-25 categorized the ICD-9 breast reconstruction
codes (Table 3) from 1 through 11, removing procedure codes that were not the breast
reconstruction codes in the study. The sum of these variables was computed into SUMRECON.
SUMRECON was then recoded into RECON, which defined reconstruction as a “1” and no
reconstruction as a “0”.
This study controlled for whether a woman had comorbidities or not, but a variable had to
be created from the two databases to define it. The sum of the twenty-nine variables listed in
Table 4 was computed into one variable called SUMCMBS, which was a continuous, count
variable. The NIS and SID databases had the same twenty-nine comorbidity variables.
Indicator variables were created for several of the independent variables to ensure that the
reference group would be the highest value in all the independent variables. All new category
descriptions were defined in the ‘Variables’ section of the methods. The first indicator variable
was AGE1. AGE1 was created by recoding AGE, a continuous variable, into seven categories.
The SID database sample size was too small to use seven categories, so it was separated into
three categories instead. In the NIS database, the ‘40-49 years old’ category is the reference
group and the ’41-64 years old’ category is the reference group for the SID database. The second
indicator variable was RACE1. The variable RACE was recoded from 1= White 2= African
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American 3= Hispanic 4= Asian or Pacific Islander 5= Native American, and 6= Other to have
the ‘African American’ category be the reference group for the NIS database. Originally, the
‘White’ category was the reference group for the NIS database, but the ‘African American’
category reference group yielded interesting results. The variable RACE was recoded into
RACE1 differently for the SID database to accommodate for sample size, and the ‘nonwhite’
category was the reference group. The last indicator variable is PAYERTYPE. PAY1 was
recoded from 1= Medicare 2= Medicaid 3= Private insurance 4= Self-pay 5=No charge 6= Other
to set the ‘Private insurance’ category as the reference group. All data preparation was completed
using IBM SPSS Statistics 25 Syntax Editor.
Statistical Analyses
Discharge records from the NIS database were obtained using a design-based complex
sample which incorporates complex weighting to produce accurate national estimates. The
HCUP database provides a weighting variable called discharge weight (DISWT) (HCUP, 2015).
DISWT was applied to the NIS database by creating a complex sample plan. All analyses and
frequencies performed for the NIS database used this complex plan as the dataset. The SID data,
on the other hand, did not require a weight variable and therefore, did not need to have a
complex sample plan.
The NIS data were analyzed using IBM SPSS Statistics 25 Complex Samples, while the
SID data were analyzed using IBM SPSS Statistics 25 Software. The statistical analysis for this
study was based on the methods used by Reuben and coauthors (2009) in a study that analyzed
predictors of PBR using NIS data from 1999 to 2003 (Reuben et al., 2009). The significance
level was set to a p < 0.05 with a confidence level of 95% for all regression models.
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For research questions 1 through 3, complex samples logistic regression models were
produced for the individual independent variables for each year for the NIS data (30 models in
total) and binary logistic regression models were created for the independent variables for the
SID data (four models in total). CMBS was not used as a covariate in the individual logistic
regression models. These models were created to analyze the association between each
independent variable and the dependent variable, RECON. After these models were produced,
independent variables were added into a model together. The NIS data produced six complex
samples multiple logistic regression models that represented each year of the database. These
models included two interaction variables. The first interaction was RACE1 and
HOS_LOCTEACH and the other was RACE1 and ZIPINC_QRTL. Six multiple binary logistic
regression models were created for the SID data representing each year occurring in the
database. Since HOSP_LOCTEACH was not a variable available in the SID database, these
models only included RACE1 and ZIPINC_QRTL as an interaction variable.
Unfortunately, due to the small sample size of PBR, models of the SID database could
not be separated by individual years and therefore had to be created for the entire dataset. It
should be noted that a small sample size can inflate the odds ratios and increase the associated
confidence intervals. Variables were kept in the model even if they were not significant. There
are known relationships between the independent variables, chosen for this study, and breast
reconstruction outcomes. The interactions are important to keep in the models because there are
also known relationships between race and SES, as well as, race and hospital characteristics with
breast reconstruction outcomes (Reuben et al., 2009; Platt et al., 2011; Shippee et al., 2014;
Kruper et al., 2011). Lastly, year trends were not calculated in this study. The change in the NIS
database sample design in 2012 made it difficult to produce trend analyses across all the years.
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Research question 4 and 5 were not analyzed by creating logistic regression models.
Frequencies were calculated for each year for the eleven categories in RECON1-15 for the NIS
data. The frequencies of the eleven categories in RECON1-25 were calculated for the entire SID
database. It is worth noting that women could have multiple breast reconstruction procedures
performed in the same surgery, meaning these frequencies represent how many procedures were
performed each year, not how many women got these breast reconstruction procedures. To
determine if specific comorbidities were prevalent in the study populations at least 10% of the
study population would need to have the comorbidity in question. Frequencies were calculated
for the twenty-nine comorbidity variables based on breast reconstruction status for each
database.
Ethical Considerations
Any identifying information was removed by AHRQ before the two HCUP databases
were received. AHRQ requires researchers to complete the HCUP Data Use Agreement Training
before using any HCUP database. The author’s completion certificate can be found in Appendix
B. A research proposal that included this study was submitted for review to the UNLV School of
Medicine Internal Review Board (IRB). This board decided that the research proposal was
exempt from IRB review (Appendix C).
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Results
The NIS Database: United States Results
In the United States, a total of 1,216,214 women between the ages of 18 to 90 years old
had a mastectomy due to breast cancer between 2008 and 2013. Out of that population, 179,923
women had PBR. The PBR rates for each year were 11.2%, 14.3%, 15.4%, 15.8%, 16.3%, and
15.9%, respectively. The maximum number of comorbidities women had in this population were
thirteen. Women who had PBR experienced one or no comorbidities 74.8% of the time, while the
women who did not have breast reconstruction had one or no comorbidities 29.9% of the time.
The median ages were 51.7 years old for women who had PBR and 63.2 years old for women
who did not have breast reconstruction. This population was predominately white, went to an
urban teaching hospital, and had private insurance, regardless of reconstruction status. The highincome quartile represented 42.1% of the PBR population, while 13.5% of the PBR population
was in the low-income quartile. For the no reconstruction population, the low-income quartile
had the highest percentage of women in it with 27.1%, while the high-income quartile had the
lowest percentage with 23.4% of the women. The results for the number of comorbidities
experienced in the United States is in Table 6. Demographic frequencies for the overall United
States model can be found in Table 7, while demographic frequencies for individual years are in
Appendix A, Table 8.
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Table 6. Number of Comorbidities Experienced in the United States
Number of
comorbidities
0
1
2
3
4
5
6
7
8
9
10
11
12
13

Reconstruction n(%)
79,368(44.1)
55,272(30.7)
28,471(15.8)
11,218(6.2)
4,000(2.2)
1,189(0.7)
302(0.2)
78(0)
15(0)
10(0)
0
0
0
0

No reconstruction
n(%)
94,031(9.1)
195,117(18.8)
226,364(21.8)
201,065(19.4)
145,587(14)
87,785(8.5)
47,803(4.6)
23,400(2.3)
9,790(0.9)
3,695(0.4)
1,221(0.1)
321(0)
87(0)
26(0)

Total n(%)
173,399(14.3)
250,389(20.6)
254,835(21.0)
212,283(17.5)
149,587(12.3)
88,974(7.3)
48,104(4.0)
23,478(1.9)
9,805(0.8)
3,705(0.3)
1,221(0.1)
321(0)
87(0)
26(0)

Table 7. Demographic Frequencies for the Overall United States
Variable

Reconstruction n(%)

No reconstruction n(%)

Median age ± SD
18-29 years old
30-39 years old
40-49 years old
50-59 years old
60-69 years old
70-79 years old
80-90 years old

51.7±10.5
2,392(1.3)
18,156(10.1)
58,919(32.7)
57,414(31.9)
34,417(19.1)
7,980(4.4)
645(0.4)

63.2±14.0
5,746(0.60)
42,255(4.1)
139,712(13.5)
226,192(21.8)
262,849(25.4)
210,266(20.3)
149,272(14.4)

White
African American
Hispanic
Asian/Pacific
Native American
Other

124,224(75.4)
16,265(9.9)
12,259(7.4)
5,629(3.4)
554(0.3)
5,756(3.5)

642,415(69.4)
153,042(16.5)
75,812(8.2)
25,446(2.7)
4,202(0.5)
25,036(2.7)

Private Insurance
Self-pay
Medicaid
Medicare
No charge
Other
Household income status
Low income
Low/middle income
High/middle income
High income
Hospital location/teaching
status
Rural
Urban nonteaching
Urban teaching

137,918(76.7)
1,689(0.9)
12,672(7.1)
22,877(12.7)
347(0.2)
4,238(2.4)

349,298(33.8)
19,869(1.9)
129,635(12.5)
509,425(49.2)
4,017(0.4)
22,327(2.2)

23,845(13.5)
32,058(18.2)
46,224(26.2)
74,306(42.1)

274,519(27.1)
254,329(25.1)
247,601(24.4)
237,167(23.4)

3,594(2.0)
56,624(31.7)
118,428(66.3)

118,033(11.5)
403,819(39.2)
507,118(49.3)

Age

Race

Payer type
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The independent variables, not controlling for comorbidities, were significant in the
individual complex samples logistic regression models. However, the interaction between race
(RACE1) and SES (ZIPINC_QRTL) was not significant for all the years in the complex samples
multiple logistic regression models. P-values for this interaction are as follows from 2008 to
2013: 0.20, <0.001, 0.16, 0.31, 0.09, and 0.5, respectively. This interaction was not significant in
the overall United States model. The interaction between race (RACE1) and hospital
characteristics (HOSP_LOCTEACH) was not significant in 2011 (p-value=0.66) and 2013 (pvalue=0.5) in the complex samples multiple logistic regression models, but it was significant in
the overall United States model. In 2012, ZIPINC_QRTL was not significant (p-value=0.13) in
that complex samples multiple logistic regression model. However, the six categories in
PAYERTYPE remained significant over the years in this study and in the overall United States
model. Results for the individual independent variable models are in Appendix A, Table 9, while
results for individual years for the complex samples multiple logistic regression models can be
found in Appendix A, Table 10.
In the overall United States complex samples multiple logistic regression model, women
between the ages of 40 and 49 years old had higher odds of having PBR than any other age
group. The 18-29 years old group was not significant during any of the years and remained not
significant in the overall United States model (OR=1.01, CI[0.89-1.15]). African American
women had lower odds of having PBR than women from any other race category in the overall
United States model. The Asian and Pacific Islander and Native American categories were not
significant in any of the models, except in 2009, with odds ratios of 0.55 (CI[0.37,0.82]) and
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0.27 (CI[0.10,0.74]). Women with private insurance had higher odds of having PBR than women
with any other payer type in the overall United States model. Women in the self-pay category
had the lowest odds of having PBR out of the six different payer type categories compared to
private insurance. Specifically, in 2011, the self-pay category had an odds ratio of 7.54
(CI[5.08,11.2]). Women in the high-income quartile had higher odds of having PBR than women
in any other income quartile. Women who had a mastectomy at a rural hospital had lower odds
of having PBR than women who had a mastectomy at an urban teaching hospital in the overall
United States model (OR=9, CI[5.50,14.7]). Similarly, women who had a mastectomy at an
urban nonteaching hospital had 1.42 lower odds of having PBR than women who had a
mastectomy at an urban teaching hospital (CI[1.29,1.56]). All results for the individual year
complex samples multiple logistic regression models are in Appendix A, Table 10, while results
for the overall United States model is in Table 11.
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Table 11: Complex Samples Multiple Logistic Regression for the Overall United States
Variable (reference group)

Odds ratio

95% C.I

1.01
1.06
1.33
1.75
3.91
31.1

0.89-1.15
1.01-1.12
1.28-1.38
1.68-1.82
3.65-4.19
25.8-37.6

0.64
0.76
1.07
0.85
0.68

0.58-0.71
0.66-0.88
0.93-1.25
0.50-1.44
0.57-0.80

4.35
3.02
1.97
5.01
1.65

3.82-4.96
2.87-3.17
1.88-2.06
3.83-6.55
1.51-1.80

Age (40-49 years old)
18-29 years old
30-39 years old
50-59 years old
60-69 years old
70-79 years old
80-90 years old
Race (African American)
White
Hispanic
Asian/Pacific
Native American
Other
Payer type (private insurance)
Self-pay
Medicaid
Medicare
No charge
Other
Household income status (high
income)
Low income
Low/middle income
High/middle income
Hospital location/teaching status
(urban/teaching)
Rural
Urban nonteaching

P-value
<0.001

<0.001

<0.001

<0.001
1.85
1.48
1.18

1.65-2.07
1.31-1.69
1.04-1.34
<0.001

9.00
1.42

5.50-14.7
1.29-1.56

Out of the eleven breast reconstruction procedures (Table 3), the insertion of breast tissue
expanders was performed 67.7% of the time in the overall United States model. The DIEP free
flap procedure was performed the most out of the autologous flap procedures (6.6%), followed
by the latissimus dorsi myocutaneous flap (5.7%). The SIEA free flap procedure was seldom
used in this study (0.3%). Unilateral and bilateral breast implants were inserted equally.
Frequencies for the breast reconstruction procedures for the overall United States and individual
years can be found in Table 12.
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Table 12. Breast Reconstruction Procedure Frequencies for the United States (individual
years & total) and Nevada (total)
Year
Reconstruction type
Unilateral breast
implant
Bilateral breast implant
Insertion of breast
tissue expander
Latissimus dorsi
myocutaneous flap
TRAM flap, pedicled

2008

2009

2010

2011

2012

2013

U.S. Total

Nevada Total

n

n

n

n

n

n

n(%)

n(%)

1,887

1,780

2,021

2,302

2,065

1,385

11,440(4.4)

80(7.6)

1,772

1,552

1,850

1,869

2,260

1,855

11,158(4.3)

128(12.1)

24,189

26,880

30,850

33,068

31,198

30,940

177,125(67.7)

645(61.0)

638

2,483

2,476

3,124

3,015

3,070

14,806(5.7)

143(13.5)

657

2,399

2,123

2,107

1,665

1,225

10,176(3.9)

25(2.4)

TRAM flap, free

667

2,044

2,046

1,533

2,240

1,945

10,475(4.0)

10(0.95)

DIEP flap, free

473

3,168

2,264

3,912

3,640

3,745

17,202(6.6)

5(0.47)

SIEA flap, free

51

242

152

93

170

160

868(0.3)

1(0.09)

GAP flap, free
Total reconstruction of
breast

5

60

30

37

50

60

242(0.09)

0(0)

108

698

541

397

455

555

2,754(1.1)

7(0.66)

Other total
reconstruction of breast

110

647

890

1,054

1,306

1,455

5,462(2.1)

14(1.3)

There were twenty-nine comorbidities analyzed in this study (Table 4). Nine of these
comorbidities were prevalent in the overall United States. Hypertension [reconstruction (R):
25.4%; no reconstruction (NR): 49.3%], hypothyroidism (R: 10.3%; NR: 13.4%) and metastatic
cancer (R: 10.2%; NR: 29.1%) were prevalent regardless of reconstruction status. Deficiency
anemias (19%), fluid and electrolyte disorders (23.7%), chronic pulmonary disease (14.9%),
depression (11.7%), diabetes (18.3%), and solid tumors without metastasis (34.8%) were
prevalent only in the population that did not have reconstruction. Results from the twenty-nine
comorbidities can be found in Table 13.

25

Table 13. Comorbidity Frequencies for the United States and Nevada
Comorbidity type
Acquired immune deficiency syndrome

U.S.
Reconstruction
n(%)
47(0)

No reconstruction
n(%)
776(0.1)

Nevada
Reconstruction
n(%)
0

No reconstruction
n(%)
4(0.1)

Alcohol abuse

632(0.4)

9,671(0.9)

5(0.7)

60(0.9)

Deficiency anemias
Rheumatoid arthritis/collagen vascular
diseases

7068(3.9)

197,211(19)

21(2.9)

1602(24.0)

2,414(1.3)

23,904(2.3)

5(0.7)

99(1.5)

Chronic blood loss anemia

503(0.3)

9,325(0.9)

1(0.1)

62(0.9)

Congestive heart failure

625(0.3)

65,645(6.3)

2(0.3)

354 (5.3)

15,215(8.5)

154,566(14.9)

58(8.1)

1096(16.4)

890(0.5)

58,956(5.7)

1(0.1)

560(8.4)

Depression

15,991(8.9)

121,072(11.7)

49(6.9)

666(10)

Diabetes

Chronic pulmonary disease
Coagulopathy

11,075(6.2)

189,681(18.3)

40(5.6)

1101(16.5)

Diabetes with chronic complications

497(0.3)

26,745(2.6)

0

97(1.5)

Drug abuse

481(0.3)

9,828(0.9)

3(0.4)

78(1.2)

Hypertension (combine
uncomplicated and complicated)

45,673(25.4)

510,952(49.3)

193(27)

3007(45.1)

Hypothyroidism

18,525(10.3)

139,273(13.4)

74(10.4)

965(14.5)

Liver disease

770(0.4)

19,935(1.9)

2(0.3)

131(2)

Lymphoma

362(0.2)

5,898(0.6)

2(0.3)

36(0.5)

Fluid and electrolyte disorders

3,250(1.8)

245,148(23.7)

7(1.0)

1765(26.5)

18,291(10.2)

301,654(29.1)

54(7.6)

2012(30.2)

Other neurological disorders

2,608(1.4)

52,173(5)

12(1.7)

354(5.3)

Obesity

12,166(6.8)

94,040(9.1)

56(7.8)

560(8.4)

Paralysis

188(0.1)

16,480(1.6)

1(0.1)

95(1.4)

Peripheral vascular disorders

598(0.3)

27,349(2.6)

1(0.1)

114(1.7)

1,952(1.1)

35,001(3.4)

4(0.6)

158(2.4)

Pulmonary circulation disorders

389(0.2)

22,966(2.2)

1(0.1)

164(2.5)

Renal failure

745(0.4)

64,052(6.2)

4(0.6)

344(5.2)

4,940(2.7)

360,575(34.8)

18(2.5)

2254(33.8)

Metastatic cancer

Psychoses

Solid tumor without metastasis
Peptic ulcer disease excluding bleeding
Valvular disease
Weight loss

14(0.0)

261(0.0)

0

5(0.1)

4,127(2.3)

32,243(3.1)

11(1.5)

154(2.3)

344(0.2)

56,239(5.4)

0

427(6.4)

*Bolded comorbidities are prevalent in the United States and Nevada

The SID Database: Nevada Results
In Nevada, there were 7,382 women between the ages of 18 and 90 years old who had a
mastectomy due to breast cancer between 2008 to 2013. Out of these women, 714 had PBR. The
PBR rate was 9.7%. Women had a maximum of twelve comorbidities. Seventy-six percent of
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women who had PBR had one or no comorbidities, while 29.3% of women who did not have
breast reconstruction had one or no comorbidities. The median ages were 52.6 years old for
women who had PBR and 62.2 years old for women who did not have breast reconstruction. Out
of the PBR population, 67.2% were between the ages of 41 and 64 years old, were predominately
white, had private insurance, and represented the high/middle income or the high-income
quartiles. The no reconstruction population was predominantly insured by Medicare (45.3%)
more than by private insurance (39.5%). The number of comorbidities experienced in Nevada is
in Table 14, while demographic frequencies for this database can be found in Table 15.

Table 14. The Number of Comorbidities Experienced in Nevada
Number of comorbidities

Reconstruction
n(%)

0
1
2
3
4
5
6
7
8
9
10
11
12

345(48.3)
198(27.7)
106(14.8)
48(6.7)
15(2.1)
1(0.1)
1(0.1)
0
0
0
0
0
0

No
reconstruction
n(%)
687(10.3)
1,265(19.0)
1,353(20.3)
1,250(18.7)
936(14.0)
612(9.2)
313(4.7)
155(2.3)
52(0.8)
35(0.5)
7(0.1)
1(0)
2(0)
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Total n(%)
1,032(14.0)
1,463(19.8)
1,459(19.8)
1,298(17.6)
951(12.9)
613(8.3)
314(4.3)
155(2.1)
52(0.7)
35(0.5)
7(0.1)
1(0)
2(0)

Table 15. Demographic Frequencies for Nevada
Variable

Reconstruction
n(%)

No
reconstruction
n(%)

106(14.8)
480(67.2)
128(18.0)
52.56 ±11.21

351(5.3)
3360(50.4)
2957(44.3)
62.15 ±13.23

55(77)
41(5.7)
51(7.1)
39(5.5)
2(0.3)
20(2.8)

4679(70.2)
796(11.9)
453(6.8)
398(6.0)
33(0.5)
207(3.1)

545(76.3)
7(1.0)
24(3.4)
122(17.1)
0(0.0)
15(2.1)

2632(39.5)
220(3.3)
576(8.6)
3023(45.3)
14(0.2)
132(2.9)

67(9.4)
133(18.6)
251(35.2)
241(33.8)

1058(15.9)
1508(22.6)
2088(31.3)
1776(26.6)

Age
18-40 years old
41-64 years old
65-90 years old
Mean ± SD age
Race
White
African American
Hispanic
Asian or Pacific Islander
Native American
Other
Payer type
Private Insurance
Self-pay
Medicaid
Medicare
No Charge
Other
Household income status
Low income
Low/middle income
High/middle income
High income

The four independent variables were significant in the individual logistic regression
models for Nevada, while ZIPINC_QRTL and the interaction between race (RACE1) and SES
(ZIPINC_INC) was not significant in the multiple logistic model. Results from the individual
logistic models can be found in Appendix A, Table 16 and results for the multiple logistic model
can be found in Table 17.
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Table 17. Multiple Logistic Regression Model for Nevada
Variable (reference group)
Age (41-64 years old)
18-40 years old
65-90 years old
Race (nonwhite)
White
Payer type (private insurance)
Self-pay
Medicaid
Medicare
Other
Household income status (high
income)
Low income
Low/middle income
High/middle income
Interaction of race and
household income
(nonwhite/high income)
White*low income
White*low/middle income
White*high/middle income

Odds ratio

95% C.I

0.73
1.60

0.55-0.95
1.16-2.20

0.65

0.45-0.93

5.00
3.62
1.90
1.85

2.30-10.9
2.32-5.65
1.37-2.62
1.05-3.25

P-Value
0.001

0.02
<0.001

0.58
1.30
1.80
0.97

0.74-2.29
0.77-2.10
0.62-1.51
0.99

0.96
0.92
1.01

0.49-1.88
0.52-1.64
0.61-1.67

In the multiple logistic regression model, women between the ages of 18 and 40 years
older had 27% higher odds of having PBR compared to women between the ages of 41 and 64
years old. When looking at the women in the 65 to 90 years old category, though, the odds were
1.6 times lower for having PBR compared to women in the 41 to 64 years old category. White
women had 35% higher odds of having breast reconstruction than nonwhite women. There were
similarities with the overall United States when it came to payer type. Self-pay had the lowest
odds ratio of having PBR compared to private insurance out of the payer type categories
(OR=5.00, CI[2.30,10.9]). The other payer type category had 1.85 (CI[1.05,3.25]) times lower
odds of having PBR compared to the private insurance category. Discharge records did not show
‘no charge’ as a payer type for women who had PBR in Nevada (Table 14). Therefore, an odds
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ratio could not be calculated. Other results from the multiple logistic regression model for
Nevada can be found in Table 17.
Inserting tissue expanders was performed the most out of the eleven breast reconstruction
procedures (61%). Out of the autologous flaps, the latissimus dorsi myocutaneous flap procedure
was used at least five times as often as any other autologous flap (13.5%). The GAP free flap
procedure was the only autologous flap procedure not performed in Nevada. Bilateral breast
implants (12.1%) were inserted more frequently than unilateral breast implants (7.6%). Breast
reconstruction procedure frequencies can be found in Table 12.
The same nine comorbidities were prevalent in Nevada that were prevalent in the United
States. Hypertension (R:27%; NR:45.1%) and hyperthyroidism (R:10.4%; NR:14.5%) were
prevalent in both the PBR and no reconstruction population, while deficiency anemias (24%),
chronic pulmonary disease (16.4%), depression (10%), diabetes (16.5%), fluid and electrolyte
disorders (26.5%), metastatic cancer (30.2%), and solid tumors without metastasis (33.8%) were
prevalent in only the no reconstruction population. Frequencies for the twenty-nine comorbidities
can be found in Table 13.
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Discussion
Hospital Location and Teaching Status
In this study, 66.3% of women in the United States had PBR at an urban teaching
hospital, while only 2% of that population had PBR at a rural hospital. Out the women who did
not have PBR, 11.5% of the women had a mastectomy at a rural hospital, while 49.3% of these
women had a mastectomy at an urban teaching hospital (Table 7). Women who had a
mastectomy at a rural or an urban nonteaching hospital had lower odds of having PBR compared
to women who had a mastectomy at an urban teaching hospital (Table 11). These results are
consistent with other researchers’ findings (Reuben et al., 2009; Kruper et al., 2011; Platt et al.,
2011).
The plastic surgeon’s location could partially explain why PBR is performed more at
urban teaching hospitals compared to rural hospitals. Plastic surgeons are not distributed equally
between urban and rural hospital settings. As of 2015, there were 53 plastic surgeons in Nevada
with 42 of them residing in Southern Nevada, 11 in Northwestern Nevada and zero plastic
surgeons in Northeastern Nevada (Griswold, Gunawan, & Packham, 2018). It is known that
teaching hospitals and hospitals in urban areas can support surgical teams who perform difficult
breast reconstruction procedures better than hospitals in rural areas (Kruper et al., 2011; Berlin,
Wilkins, & Alderman, 2018). One study analyzed the relationship between plastic surgeon
density in small geographic areas and breast reconstruction rates in 10 states. The researchers
found that approximately half of the variation in breast reconstruction rates (delayed and
immediate) between urban and rural areas could be explained by the density of plastic surgeons
per people during 2010 (Bauder et al., 2017).
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Additionally, PBR rates can be negatively impacted by how difficult it is to coordinate
the schedules of plastic and general surgeons to perform PBR at rural hospitals (Rubin, Chavez,
Alderman, & Pusic, 2013; Berlin, 2018; Bauder et al., 2017). In the United States, more plastic
surgeons who perform PBR are needed to increase the access of these procedures in rural areas
and, in general, to fill the void of the large number of retiring plastic surgeons (Noone, Goldwyn,
McGrath, Spear, & Evans, 2007). Several studies suggested that allowing general surgeons to
perform breast reconstruction procedures, instead of only mastectomies, would help increase
access to PBR. This concept has worked internationally in other medical fields, such as
otolaryngology (Berlin et al., 2018; Bauder et al., 2017; Winters, Pou, & Friedlander, 2011).
Limited access to PBR in rural areas has the potential to negatively affect the 274,622 Nevadans
living in rural Nevada (Rural Health Information Hub [RHIhub], 2019). This study could not
assess the relationship between rural hospitals in Nevada and PBR rates due to the unavailability
of a hospital location variable or a similar variable in the SID database.
In addition to the reasons stated above, living in specific regions of the United States can
positively impact PBR rates. Reuben et al. (2009) concluded, between 1999 and 2003, women
who received care in the South had increased odds of having PBR than women who received
care in the Midwest, Northeast, or the West. The authors mentioned that PBR was first
established in hospitals in the South, which increased the number of plastic surgeons available
there (Reuben et al., 2009). An older study found different results though. Women in the South
and the Midwest were less likely to have PBR compared to the Mountain and Pacific regions
during 1994-1995 (Morrow et al., 2001). Hospital region was not analyzed as an independent
factor for PBR because this study was concerned with the United States, as a whole, and Nevada.
Delayed and Outpatient Breast Reconstruction
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Between 2008 and 2013, PBR rates in the United States ranged from 11.2%-15.9%, while
the PBR rate in Nevada was 9.7% in this study. United States PBR rates have decreased roughly
10% since 2003 (25.3%) when using data obtained by the NIS database (Reuben et al., 2009).
The cause of decreasing PBR rates in the NIS database is not entirely understood.
Increasing outpatient breast cancer treatment surgeries could provide an explanation, but
there is conflicting information in the literature. According to a study that analyzed data from 28
states via SID databases and State Ambulatory Surgery and Services Databases (SASD),
outpatient mastectomies accounted for 43% of all mastectomy surgeries in 2012 (Steiner et al.,
2016). In contrast, a study that used Californian data found that outpatient mastectomy rates
(20.4% to 23.9%) did not increase as much as inpatient mastectomy rates (29.2% to 41.6%)
during 2006-2009. Moreover, the authors concluded that while outpatient PBR rates increased
from 7.7 to 10.3%, inpatient PBR was more popular, and the rates increased from 29.2% to
41.6% (Kruper et al., 2011). Bauder et al. (2017) found that in their study population only 15.5%
of the women received a mastectomy in an outpatient setting and their overall (immediate and
delayed) breast reconstruction rate was 44.7% (Bauder et al., 2017). Another study that used SID
databases and SASD found that inpatient PBR rates remained constant during 2009-2014 (7.4 to
7.3 per 100,000 women), while outpatient PBR rates increased by 155% (1.1 to 2.8 per 100,000
women). Even though there was an increase in outpatient PBR rates during this study, PBR was
performed in an inpatient setting more (Miller, Steiner, Barrett, Fingar, & Elixhauser, 2017).
Like outpatient breast cancer treatment surgeries, DBR rates have increased over the
years. One study found a 10.1% increase in DBR from 2009 to 2014 in 22 states. Specifically, in
2014, 71% of the overall breast reconstruction rate was from DBR procedures (Miller et al.,
2017). Those results are different from a study that analyzed data from the Mastectomy
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Reconstruction Outcomes Consortium (MROC) from 2012 to 2015. This study resulted in only
7.7% of the study population choosing to have DBR. The authors found that women who needed
radiation therapy, in conjunction with a mastectomy, had lower complication rates if they waited
to have breast reconstruction until after their treatment was completed (Yoon et al., 2018). DBR
is more popular in older women who have several comorbidities, and in women who live in rural
areas. Even though DBR has been shown to have lower complication rates for specific
procedures, like autologous flaps, plastic surgeons still prefer to perform PBR when possible
(Bauder et al., 2017; Yoon et al., 2018).
Breast Reconstruction Procedures
The most popular breast reconstruction procedure was the insertion of breast tissue
expanders in the United States and Nevada (Table 12). During breast reconstruction, surgeons
may use tissue expanders, in combination, with other procedures, explaining the large number of
tissue expander insertion in this study (McCue et al., 2010; Boehmler & Butler, 2010). When
examining the use of breast implants, Nevadan surgeons inserted breast implants more often
(19.6%) than surgeons in the United States did (8.7%). U.S. surgeons performed autologous flap
procedures 20.59% of the time, while 17.4% of the time, Nevadan surgeons performed
autologous flap procedures.
Although this study only analyzed the frequencies of breast reconstruction procedures,
there are known relationships between different subpopulations of women and specific breast
reconstruction procedures. Women 35 years old and younger, and, women between the ages of
65 and 74 years old preferred having breast implants over any other procedures (Alderman,
McMahon, & Wilkins, 2003; Butler et al., 2016). African American women prefer having
autologous flap procedures more than having breast implants (Rubin et al., 2013). Lastly, women
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who had DBR were more likely to have an autologous flap procedure than any other
reconstruction options (Yoon et al., 2018).
Comorbidities
The same nine comorbidities were prevalent in the United States and Nevada in this
study. On average, women who did not have breast reconstruction had more comorbidities than
women who had PBR. This finding is consistent with other results about comorbidities in the
literature. Several studies concluded that women with multiple medical conditions were less
likely to have breast reconstruction than other women, or at least have more post-surgical
complications (Yoon et al., 2018; Kruper et al., 2013; Veronesi et al., 2011). Butler et al. (2016)
found that moderately obese women (30-34.9 kg/m2) had 1.46 higher odds (p-value= <0.001) of
having post-surgical complications than women who were not obese (<30 kg/m2). The
complications reported in this study were minor, like wound infection and breast implant
failures. Though this study stated that morbidly obese women were more likely to have major
complications than other women, it was determined that age and race were not independent
predictors of post-surgical complications. Other comorbidities, such as cardiovascular disease
and smoking, increased the odds of having complications after surgery (Butler et al., 2016).
Lastly, physicians are less likely to discuss breast reconstruction options with women who have
several comorbidities due to the increased risk of additional surgery (Veronesi et al., 2011).
Age
The median age of women having PBR has not changed for the United States since 2003
(Reuben et al., 2009). Median ages for women having PBR in Nevada and the United States
were similar (Table 7 & Table 15). When age was analyzed in the individual logistic regression
model, the gap between older and younger women having PBR was larger than the gap in the
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multiple logistic regression model for both the United States and Nevada (Table 9; Table 11;
Table 16; Table 17). There are several possible explanations for this gap increase, one could be
that women who did not have PBR had more comorbidities than younger women in this study.
Even when comorbidities were considered, older women do not have PBR as often as younger
women. This finding is consistent with the known relationship between age and PBR mentioned
in other studies (Reuben et al., 2009, Butler et al., 2016; Alderman et al., 2003; Morrow et al.,
2001; Kruper et al., 2011; Veronesi et al., 2011).
Payer Type, Race, and Socioeconomic Status
This study found that nonwhite women had 35% lower odds of having PBR than white
women in Nevada (Table 17), while African American women had lower odds of having PBR
compared to women of other races in the United States (Table 11). These results are similar to
other studies (Yang et al., 2013; Kwok et al., 2015). Several studies have shown that Asian
women are one-third as likely as white women to have PBR (McGuire et al., 2009; Kruper et al.,
2011; Kwok et al., 2015). Another study found that Middle Eastern and Hispanic women the
same odds for having PBR compared to white women, but African American and Asian women
did not (Tseng et al., 2004). Interestingly, Reuben et al. (2009) concluded that race was only a
significant predictor of PBR when hospital characteristics were controlled for (Reuben et al.,
2009) The interaction between race and hospital location/teaching status was significant in the
multiple logistic regression model for the overall United States, but not for all the individual
years.
Researchers agree that African American women are disproportionately less likely to
have PBR than white women (Alderman et al., 2009; Kruper et al., 2011). African American
women are diagnosed with early-stage breast cancer less than other women (Rubin et al., 2013).
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Later-stage cancer diagnoses can contribute to their lower PBR rates since mastectomies are
recommended for early-stage breast cancer treatment (American Cancer Society, 2015). It should
be mentioned that Morrow et al. (2005) concluded that African American women continued to
have lower breast reconstruction rates after controlling for several factors, including the stage of
breast cancer (Morrow et al., 2005). These authors provide evidence that other factors impact the
low PBR rates in African American women. Alderman et al. (2009) found that African American
women were less likely to have a consultation with a plastic surgeon than other women
(Alderman et al., 2009). In addition, it has been reported that oncologists have shorter visits and
have less discussion about their illness with African American patients (Mahmoundi, Lu, Metz,
Momoh, & Chung, 2018). In one study, African American women agreed that they had less
discussion, than desired, with their physician about the breast reconstruction options and they felt
that their physician discouraged them from having PBR (Alderman et al., 2009). These results
could partially be due to physician bias (Alderman et al., 2003) or from other reasons due to the
patient’s health. Furthermore, medical distrust continues to affect the African American
population from historical experiments that were unethical. (Rubin et al., 2013; Mahmoundi et
al., 2018; Butler, Familusi, Serletti, & Fox, 2018).
Nevada has a diverse population, with more than half of the population identifying as a
different race than white. As of 2017, 31.1% of Nevadans speak a different language than
English at home (U.S Census Bureau, 2017). Language barriers are contributing to lower PBR
rates in women of color. Berlin et al. (2018) discussed that women who primarily speak Spanish
seldom have PBR compared with other minority women (Berlin et al.,2018). Moreover, a study
found that only 37% of medical graduates speak another language besides English (Mahmoundi
et al., 2018). The absence of effective communication between a woman and her doctor could
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negatively impact her decision on breast reconstruction, if she doesn’t fully understand her
options (Yang et al., 2013; Shippee et al., 2014). Overall, minorities feel that they receive less
counseling on breast reconstruction options and desire more information than provided
(Alderman et al., 2009).
SES has a tremendous impact on PBR rates (Mahmoundi et al., 2018). In this study,
household income status was only significant in the United States while women with highincome had higher odds of having PBR than the other income categories. The interaction
between race and SES, however, was not significant in the multiple logistic regression models
for the overall United States and Nevada. It is known that low-income women are less likely to
have PBR than other women (Shippee et al., 2014). A few reasons these lower rates, include the
amount of time they would have to take off from work, lack of insurance or inadequate insurance
coverage, and less access to hospitals that can accommodate PBR procedures (Kruper et al.,
2011; Yang et al., 2013; Alderman et al., 2003).
Other studies use payer type information as an indicator for SES since race disparities can
be enhanced by unequal access to payer type (Kruper et al., 2011; Shippee et al., 2014). Women
of color who had public insurance coverage were less likely to have PBR than white women with
the same coverage (Rubin et al., 2013; Tseng et al., 2004; Shippee et al., 2014; Butler et al.,
2018). Payer type was an independent predictor of PBR in this study; the results were consistent
with other studies. There was a disparity between the categories of payer type and private health
insurance. Reimbursement differences among payer types are one contributing factor to
racial/ethnic disparities. Private insurance has higher reimbursement rates for PBR and has lower
out of pocket expenses for patients than other payer types. Therefore, plastic surgeons limit how
many patients they have on public health insurance due to the lower reimbursement rates
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(Bauder et al., 2017; Shippee et al., 2014; Kruper et al., 2011). Financial concerns and lack of
private health insurance may be a factor in why women of color have lower rates of plastic
surgeon consultations (Alderman et al., 2009). As demonstrated, racial/ethnic disparities of PBR
have influences from various independent predictors, making it difficult to understand and
address thoroughly.
Physician-Patient Discussions and Patient Preferences
According to the literature, two factors have considerable influence on women’s breast
reconstruction decision, discussions with physicians and the woman’s personal preference.
Greenberg et al. (2008) concluded that the primary predictor for a woman to have PBR was a
documented discussion on the various options between the woman and her physician in their
study (Greenberg et al., 2008; Mahmoundi et al., 2017). As mentioned in the previous section,
this discussion does not happen for every woman. Physicians’ knowledge about breast PBR
options directly affects these discussions. A study based in Wisconsin reported that 40% of the
general surgeons surveyed did not refer all their patients for breast reconstruction (Stacey et al.,
2008). Some of the reasons for not referring breast reconstruction to patients included concerns
about cancer reoccurrence and patient’s age. A patient’s age alone should not deter physicians
from discussing breast reconstruction options with patients (Reuben et al., 2009; Greenberg et
al., 2008). Also, in the background section of this study, it was discussed that breast
reconstruction does not hinder detecting cancer reoccurrences. Wanzel et al. (2002) found that
90% of the plastic surgeons surveyed believed that not all women who were qualified for breast
reconstruction were being referred to them because of a lack of physician knowledge on this
topic. In addition, the authors confirmed that lack of correct knowledge is a common reason why
women do not have breast reconstruction (Wanzel, Brown, Anastakis, & Regehr, 2002). Not all

39

studies believe this statement though. Some studies found that women who had high knowledge
of breast reconstruction options still did not have breast reconstruction (Rubin et al., 2013;
Morrow et al., 2005).
Patient preferences are significant contributing factors in the decision-making process on
PBR. These preferences can be more influential than a physician’s advice or opinion (Morrow et
al., 2005). One subpopulation where this statement may not be true is with older women. It is
found that physicians opinion of breast reconstruction may impact an older woman’s decision
more than it would their younger counterpart (Morrow et al., 2001). A reason could be that older
women are more passive about breast reconstruction decisions and give their physician’s advice
more power than younger women would (Alderman et al. 2003; Veronsi et al., 2011). On the
other hand, older women may be passive about not learning more breast reconstruction because
they don’t want to have additional surgery, which is a personal preference (Alderman et al.,
2003).
Policy
The WHCRA did not reduce the racial/ethnic disparities associated with PBR (Rubin et
al., 2013; Shippee et al., 2014; Kruper et al., 2011; Yang et al., 2013). In fact, researchers
suggest that the WHCRA caused these disparities to widen even more (Mahmoundi et al., 2017).
The reason is that the WHCRA did not introduce any regulations that controlled the differences
between private and public insurance reimbursement rates (Butler et al., 2018; Rubin et al.,
2013). The disparities that form when payer types have different reimbursement rates for
procedures has been discussed, but the group that is usually most impacted are minority women
causing the disparity to grow (Shippee et al., 2014).
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Since the WHCRA, several pieces of legislation have been introduced to try and decrease
the racial/ethnic disparities in healthcare and increase knowledge of breast reconstruction
options. The first piece of legislation is the Patient Protection and Affordable Care Act of 2010
(ACA). The ACA is a healthcare reform law that provides subsidies to lower the cost of health
insurance, which in turn, increases the access to healthcare. It mandated that all individuals need
to have health insurance and insurance companies cannot deny access to people with preexisting
conditions or people with a history of cancer care (Davis, Abrams, & Kristof, 2011). The ACA
was enacted on March 23rd, 2010, and it took until January 1st, 2014 for most of the healthcare
changes to happen (eHealth, 2018). One provision of the ACA was a Medicaid expansion
program. States were allowed to choose whether or not they wanted to participate in it. This
expansion would allow individuals to qualify for Medicaid if their income was under 138% of
the federal poverty level. As of 2017, 31 states and Washington D.C choose to participate in the
Medicaid expansion. In 2014, Nevada agreed to the Medicaid expansion (McGinley &
Goldstein, 2017). In this study, there was an increase in Medicaid and Medicare coverage when
comparing 2008 to 2013 for both Nevada and the United States (Table 18). Research shows that
the ACA did reduce the overall racial/ethnic disparity in healthcare access (Chen, VargasBustamanate, Mortensen, & Oretga, 2016; Davis et al., 2011; Shippee et al., 2014).

Table 18. Percent of Women Covered by Insurance in 2008 and 2013 for United States and
Nevada
Year
United States

Private Insurance

Medicaid

Medicare

Other

2008
2013

42.2%
37.8%

9.9%
12.5%

43.2%
45.5%

2.6%
2.1%

2008
2013

45.9%
36.7%

6.8%
9.4%

39.9%
47.1%

4.3%
2.4%

Nevada
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The next piece of legislation is the New York Public Health (NY PBH) Law 2803-O
(2011). This law was enacted on January 1st, 2011. It mandates that general hospitals must
provide specific information to every patient having breast cancer treatment surgery. They must
offer inpatient care after the surgery to every patient, as well as, provide information on the
breast reconstruction options to every patient. This information needs to include; advantages and
disadvantages of breast reconstruction procedures, how to access breast reconstruction care if
that hospital does not offer it and how to acquire breast reconstruction after other treatments are
finished, and the commissioner may require additional information as well. All information must
be provided in written form, so that patients can refer to it later (NY PBH 2803-O, 2011).
Mahmoundi et al. (2017) analyzed the effect of this law on breast reconstruction in New York
during 2008-2011. The study resulted in three main findings; this law did not increase the overall
PBR rate, it did not decrease the disparity between African American women and white women,
but this law did decrease the disparity between Hispanic and white women, as well as, reducing
the disparity between white women and other minorities (Mahmoundi et al., 2017).
The last piece of legislation that was introduced after the WHCRA to increase knowledge
of breast reconstruction options is the Breast Cancer Patient Education Act of 2015. Two bills
were introduced in the 114th U.S. legislative session, Senate Bill 1192 (2015) and House of
Representative Bill 2540. Both these bills aimed to amend the Public Service Act to require the
Department of Health and Human Services to plan and implement a breast reconstruction
education campaign targeted towards women of color breast cancer patients (S.1192, 2015;
H.R.2540, 2015). On December 18th, 2015, Congress enacted the Breast Cancer Patient
Education Act (American Society of Plastic Surgeons, 2015). Overall, there is a national and
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state level effort to implement policies that will decrease the racial/ethnic disparities in
healthcare and increase knowledge of breast reconstruction options.
Limitations
There were several limitations of this study. In secondary analyses, researchers do not
decide what information is collected nor do they collect the data themselves. The NIS and SID
databases use discharge records from various hospitals. It is possible that errors could have
occurred when recording patient information, diagnosis and procedure codes, and hospital
information. With discharge records in HCUP databases, it is difficult to determine if the same
patient had multiple discharge records since they are not linked to patients. In addition, there was
specific hospital characteristic information collected in the NIS database that was not available in
the SID database. Due to this lack of information, this study was not able to determine the
relationship between hospital location and teaching status and PBR rates in Nevada.
Another limitation of this study was the use of inpatient discharge records. In this study,
the PBR rates produced are representative of PBR surgeries performed in an inpatient setting, but
not of all the PBR surgeries in the United States and Nevada. Since trends show an increase in
outpatient breast cancer treatment surgeries, this is a significant limitation. Also, the use of these
discharge records didn’t allow this study to determine DBR rates for the United States and
Nevada. The discharge records used only account for past and current procedures, meaning it
cannot be determined if patients had DBR in the future.
Future Public Health Policy and Research Recommendations
This study illustrates the continuation of disparities among age, payer types,
race/ethnicities, and SES in PBR seen in previous years in the United States. The implementation
of several policies has occurred in the last twenty years to try and decrease these disparities.
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Further analysis of how effective policy efforts are on increasing minorities’ breast
reconstruction rates at a state level is needed. Evidence has been provided by Mahmoundi et al.
(2017) that shows the impact mandated education for breast cancer patients had on racial/ethnic
disparities of PBR in New York (Mahmoundi et al., 2017). In addition to research, policy makers
should ensure that federally mandated education is available in multiple languages, as well as,
representative of all of cultures. Lastly, the American Society of Plastic Surgeons and policy
makers should develop programs that will increase access to breast reconstruction in rural areas.
Multiple studies, including this one, have provided evidence to show that quantitative
research alone cannot explain the differences in the breast reconstruction decision-making
process among women. Discussions about breast reconstruction options and patient preferences
are two factors that influence this decision-making process. More qualitative and mixed-methods
research on these factors are needed to explain the variation in PBR rates among women in the
United States and Nevada. Furthermore, additional research on outpatient breast reconstruction
procedures and DBR is needed to gain a better understanding of the overall breast reconstruction
rates in the United States and Nevada.
To the author’s knowledge, no published studies have analyzed state-specific data on
PBR in Nevada. This study provided information on the variation that occurs among women who
have PBR and who do not. The data used in this study was not the most recent data available.
Additional research with more recent data on PBR is needed to understand the disparities of PBR
in Nevada better.
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Conclusion
The purpose of this study was to determine factors that are associated with women
choosing whether or not to have PBR in the United States with more recent data. Additionally,
this study aimed to provide insight into the specific groups of women who do or do not choose to
have PBR in Nevada. Women who are younger, white, have private insurance, and seek care at
an urban teaching hospital continue to be more likely to have PBR than other women. Despite
the efforts of the WHCRA, disparities among age, payer types, racial/ethnic groups, and
socioeconomic statuses in PBR still exist in the United States and Nevada. Research discussed in
this study provides evidence that the breast reconstruction decision-making process is complex
and relies heavily on patient’s knowledge of breast reconstruction options, patient-physician
based discussions, and patient preferences. Nevada should use New York as an example and
implement policies that mandate education on breast reconstruction options for all patients
receiving breast cancer treatment surgery. In addition, plastic surgeons and policy makers should
develop programs that will increase access to breast reconstruction in rural areas.
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Appendices
Appendix A: Tables

Table 8. Demographic Frequencies for Individual Years in the United States
2008

2009

2010

Reconstruction
n(%)

No
reconstruction
n(%)

Reconstruction
n(%)

No
reconstruction
n(%)

Reconstruction
n(%)

No
reconstruction
n(%)

18-29 years old

327(1.4)

1029(0.6)

414(1.4)

938(0.5)

447(1.4)

1,184(0.7)

30-39 years old

2,415(10.4)

8,139(4.5)

2,941(10.1)

7,124(4.1)

3,290(10.4)

6,874(4.0)

40-49 years old

7,831(33.8)

27,149(14.9)

9,794(33.5)

24,003(13.7)

10,606(33.6)

24,714(14.2)

50-59 years old

7,261(31.4)

40,132(22)

9,300(31.8)

38,214(21.8)

10,076(31.9)

38,429(22.1)

60-69 years old

4,118(17.8)

43,738(23.9)

5,503(18.8)

43,388(24.8)

5,675(18)

43,872(25.2)

70-79 years old

1,125(4.9)

36,509(20)

1,140(3.9)

36,264(20.7)

1,360(4.3)

34,983(20.1)

80-90 years old

78(0.3)

26,009(14.2)

110(0.4)

25,332(14.5)

139(0.4)

23,758(13.7)

15,118(79.5)

107,069(72.7)

19,469(76.1)

104,770(69.6)

22,70(77.3)

106,406(68.6)

African American

1,475(7.8)

20,703(14.1)

2,237(8.7)

23,557(15.6)

2,929(10)

27,723(17.9)

Hispanic

1,094(5.8)

11,088(7.5)

1,957(7.7)

12,531(8.3)

2,141(7.3)

13,036(8.4)

698(3.7)

4,251(2.9)

899(3.5)

4,170(2.8)

814(2.8)

3,673(2.4)

Variable
Age

Race
White

Asian/Pacific
Native American

49(0.3)

553(0.4)

222(0.9)

749(0.5)

56(0.2)

685(0.4)

Other

583(3.1)

3,592(2.4)

794(3.1)

4,769(3.2)

732(2.5)

3,672(2.4)

18,384(79.5)

68,339(37.4)

22,892(78.5)

59,796(34.2)

24,452(77.5)

59,284(34.2)

247(1.1)

3,047(1.7)

327(1.1)

3,906(2.2)

238(0.8)

3,623(2.1)

Medicaid

1,074(4.6)

19,244(10.5)

1,707(5.9)

21,590(12.3)

2,281(7.2)

24,383(14.1)

Medicare

2,928(12.7)

85,937(47.1)

3,355(11.5)

85,760(49)

3,920(12.4)

81,943(47.2)

No charge

54(0.2)

1,112(0.6)

50(0.2)

556(0.3)

66(0.2)

915(0.5)

Other

437(1.9)

4,828(2.6)

833(2.9)

3423(2.0)

610(1.9)

3,314(1.9)

2,722(12)

46,387(25.8)

3,726(13.1)

46,406(27.3)

4,296(13.9)

47,655(28.1)

4,379(19.3)

47,559(26.5)

5,103(17.9)

44,793(26.4)

5,522(17.9)

40,966(24.2)

5,686(25)

42,209(23.5)

7,273(25.6)

39,598(23.3)

7,719(25)

41,564(24.5)

9,936(43.7)

43,341(24.1)

12,347(43.4)

39,191(23.1)

13,372(43.3)

39,374(23.2)

Payer type
Private Insurance
Self-pay

Household income
status
Low income
Low/middle income
High/middle
income
High income
Hospital
location/teaching
status
443(1.9)

21,804(12)

702(2.5)

21,034(12.2)

680(2.2)

20,509(11.9)

Urban nonteaching

Rural

7,616(32.9)

73,644(40.4)

9834(34.4)

73,067(42.5)

9,568(30.7)

68,217(39.6)

Urban teaching

15,089(65.2)

87,003(47.7)

18,025(63.1)

77,704(45.2)

20,933(67.1)

83,417(48.5)
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Table 8 cont. Demographic Frequencies for Individual Years in the United States
2011

2012

2013

Reconstruction
n(%)

No
reconstruction
n(%)

Reconstruction
n(%)

No
reconstruction
n(%)

Reconstruction
n(%)

No
reconstruction
n(%)

18-29 years old

444(1.3)

981(0.5)

385(1.2)

795(0.5)

375(1.2)

820(0.5)

30-39 years old

3,141(9.3)

7,252(4.0)

3370(10.5)

6,805(4.1)

3,000(10.0)

6,060(3.8)

40-49 years old

11,087(32.9)

23,637(13.1)

10,310(32.1)

20,815(12.6)

9,290(30.8)

19,395(12.2)

50-59 years old

10,661(31.6)

38,657(21.5)

10,255(31.9)

35,810(21.6)

9,860(32.7)

34,950(22.0)

60-69 years old

6,782(20.1)

47,101(26.2)

6,235(19.7)

43,255(26.1)

6,020(20.0)

41,495(26.1)

70-79 years old

1,481(4.4)

37,045(20.6)

1,395(4.3)

32,860(19.9)

1,480(4.9)

32,605(20.5)

80-90 years old

118(0.3)

25,443(14.1)

110(0.3)

25,180(15.2)

90(0.3)

23,550(14.8)

White

23,716(75.4)

113,167(68.5)

22,475(73.2)

107,960(68.8)

20,725(72.6)

103,045(68.3)

African American

3,253(10.3)

29,549(17.9)

3,275(10.7)

25,660(16.3)

3,095(10.8)

25,850(17.1)

Hispanic

Variable
Age

Race

2,482(7.9)

13,571(8.2)

2,185(7.1)

12,880(8.2)

2,340(8.4)

12,705(8.4)

Asian/Pacific

994(3.2)

4,157(2.5)

970(3.2)

4,485(2.9)

1,255(4.4)

4,710(3.1)

Native American

56(0.2)

665(0.4)

105(0.3)

885(0.6)

65(0.2)

665(0.4)

Other

962(3.1)

4,044(2.4)

1,675(5.5)

5,130(3.3)

1,010(3.5)

3,830(2.5)

Payer type
Private Insurance

25,845(76.7)

60,134(33.5)

24,140(75.2)

52,675(31.9)

22,205(73.8)

49,070(30.9)

Self-pay

221(0.7)

2,902(1.6)

390(1.2)

3,235(2.0)

265(0.9)

3,155(2.0)

Medicaid

2,230(6.6)

22,408(12.5)

2,655(8.3)

21,225(12.8)

2,725(9.1)

20,785(13.1)

Medicare

4,538(13.5)

89,671(49.9)

4,185(13.0)

84,160(50.9)

3,950(13.1)

81,955(51.7)

No charge

57(0.2)

479(0.3)

55(0.2)

420(0.3)

65(0.2)

535(0.3)

Other

793(2.4)

4,097(2.3)

680(2.1)

3,505(2.1)

885(2.9)

3,160(2.0)

Low income

4,586(13.8)

48,110(27.2)

4,490(14.2)

44,875(27.7)

4,025(13.6)

41,085(26.4)

Low/middle income
High/middle
income
High income

5,780(17.4)

41,890(23.7)

5,680(18.0)

38,730(23.9)

5,595(18.9)

40,340(26.0)

9,081(27.4)

46,065(26.0)

8,545(27.0)

39,390(24.3)

7,920(26.8)

38,775(24.9)

13,690(41.3)

40,955(23.1)

12,900(40.8)

39,090(24.1)

12,060(40.7)

35,215(22.7)

584(1.7)

20,246(11.4)

635(2.0)

17,520(10.6)

550(1.8)

16,920(10.6)

Urban nonteaching

11,506(34.4)

70,466(39.5)

9360(29.1)

61,205(37.0)

8,740(29.0)

57,220(36.0)

Urban teaching

21,402(63.9)

87,464(49.1)

22,155(68.9)

86,795(52.4)

20,825(69.2)

84,735(53.3)

Household income
status

Hospital
location/teaching
status
Rural
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Table 9. Complex Samples Logistic Regression Models for Independent Variables in the
United States
2008
Variable (reference
group)
Age (40-49 years old)

2009

OR

C.I

18-29 years old

0.91

30-39 years old

Pvalue
<0.001

2010

OR

C.I

0.69-1.20

0.92

0.97

0.87-1.09

50-59 years old

1.60

60-69 years old

Pvalue
<0.001

OR

C.I

0.71-1.20

1.14

0.89-1.46

0.99

0.89-1.10

0.90

0.81-1.00

1.47-1.72

1.68

1.56-1.80

1.64

1.52-1.76

3.07

2.80-3.36

3.22

2.96-3.49

3.32

3.06-3.60

70-79 years old

9.37

8.12-10.80

13.0

11.2-15.0

11.0

9.68-12.6

80-90 years old

96.3

58.7-158

93.7

61.8-142

73.6

50.2-108

Race (African
American)

<0.001

<0.001

<0.001

White

0.51

0.45-0.57

0.51

0.46-0.57

0.50

0.45-0.54

Hispanic

0.72

0.60-0.86

0.61

0.53-0.70

0.64

0.56-0.74

Asian/Pacific

0.43

0.35-0.54

0.44

0.37-0.53

0.48

0.39-0.58

Native American

0.80

0.41-1.55

0.32

0.22-0.46

1.29

0.69-2.41

Other

0.44

0.35-0.55

0.57

0.47-0.69

0.53

0.44-0.65

Payer type (private
insurance)

<0.001

<0.001

<0.001

Self-pay

3.32

2.48-4.44

1.57

1.32-1.88

6.27

4.66-8.42

Medicaid

4.82

4.19-5.54

4.23

2.05-8.72

4.41

3.98-4.88

Medicare

7.89

7.22-8.63

9.79

8.99-10.7

8.62

7.96-9.34

No charge

5.57

3.04-10.2

4.84

4.31-5.44

5.72

3.25-10.1

Other

2.97

2.39-3.69

4.57

3.53-5.92

2.24

1.84-2.73

Household income
status (high income)

<0.001

<0.001

<0.001

Low income

3.91

3.54-4.31

3.92

3.59-4.28

3.77

3.47-4.09

Low/middle income

2.49

2.29-2.71

2.77

2.56-2.99

2.52

2.33-2.72

High/middle income

1.70

1.57-1.84

1.72

1.60-1.84

1.83

1.70-1.96

Hospital
location/teaching
status
(urban/teaching)

<0.001

<0.001

<0.001

Rural

8.53

6.87-10.6

6.95

5.86-8.25

7.57

6.42-8.93

Urban nonteaching

1.68

1.57-1.79

1.72

1.62-1.83

1.79

1.69-1.90
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Pvalue
<0.001

Table 9 cont. Complex Samples Logistic Regression Models for Independent Variables in
the United States
201
1
Variable
(reference
group)
Age (40-49
years old)
18-29 years
old
30-39 years
old
50-59 years
old
60-69 years
old
70-79 years
old
80-90 years
old
Race (African
American)

OR

2012

C.I

1.04
1.08
1.70
3.26
11.7
101

C.I

0.811.33
0.981.20
1.591.82
3.023.51
10.413.3

1.02
1.00
1.73
3.39
11.7

67.9-151

113

Hispanic

0.60

Asian/Pacific

0.46

Native
American

1.30

Other

0.46

0.480.57
0.530.68
0.390.55
0.712.37
0.390.55

Payer type
(private
insurance)

0.781.35
0.901.11
1.611.86
3.133.67
10.213.3
74.3173

5.63

0.61
0.75
0.59
1.08
0.39

Medicaid

4.32

Medicare

8.49

No charge

3.62

Other

2.22

4.177.60
3.904.78
7.909.13
1.986.59
1.882.63

Household
income status
(high income)

2.42
1.70

3.66
9.22
3.50
2.36

8.48

Urban
nonteaching

1.50

1.0110.3
1.421.58

1.70
3.30
10.6
125

3.30

0.60
0.63
0.45
1.23
0.45

2.25
1.52

3.45
9.39
3.73
1.62

1.67

2.47
1.68

3.22
11.1
97.7

<0.001
0.55
0.66
0.48
0.81
0.46

0.530.57
0.620.70
0.450.52
0.660.99
0.430.50
<0.001

4.65
4.04
8.79
4.57
2.08

4.155.19
3.874.22
8.519.08
3.565.87
1.932.24

3.213.81
2.292.67
1.561.80

<0.001
3.61
2.49
1.68

3.483.74
2.412.57
1.631.73

<0.001

7.56
1.61
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1.66

0.911.13
0.941.03
1.611.71
3.123.33
10.511.7
82.1116

<0.001
3.50

5.888.43
1.571.77

0.98

4.067.15
3.143.80
8.6710.2
2.096.63
1.361.92

6.239.17
1.511.74

Pvalue
<0.001

1.01

0.540.65
0.560.72
0.380.53
0.692.18
0.380.54

<0.001

7.04

C.I

<0.001
5.39

3.043.58
2.082.43
1.421.63

OR

<0.001

<0.001

<0.001

Rural

0.97

3.004.82
3.334.04
8.539.96
1.876.57
1.962.85

Pvalue

0.791.38
0.871.08
1.581.83
3.043.58
9.2812.0
78.6200

<0.001
3.80

3.243.80
2.252.61
1.591.81

C.I

<0.001
1.05

0.560.67
0.660.86
0.500.70
0.681.70
0.340.45

<0.001
3.51

OR

<0.001

<0.001

Self-pay

Pvalue

Overall NIS database

<0.001

<0.001
0.53

Low/middle
income
High/middle
income
Hospital
location/teach
ing status
(urban/teachi
ng)

OR

<0.001

White

Low income

Pvalue

2013

<0.001

7.67
1.67

7.118.27
1.631.71

Table 10. Complex Samples Multiple Logistic Regression for Individual Years in the
United States
2008
Variable (reference
group)
Age (40-49 years old)

2009

OR

C.I

18-29 years old

0.73

30-39 years old

Pvalue
<0.001

2010

OR

C.I

0.53-1.01

0.87

0.98

0.85-1.12

50-59 years old

1.27

60-69 years old

1.68

70-79 years old
80-90 years old

Pvalue
<0.001

OR

C.I

0.62-1.22

1.16

0.85-1.57

1.02

0.90-1.17

1.01

0.89-1.14

1.15-1.40

1.35

1.23-1.48

1.36

1.24-1.48

1.50-1.89

1.72

1.55-1.91

1.94

1.76-2.15

3.28

2.70-3.97

4.61

3.85-5.51

4.23

3.59-4.99

31.8

18.0-55.8

26.6

17.15-41.1

27.1

17.6-41.5

Race (African
American)

<0.001

<0.001

<0.001

White

0.69

0.52-0.93

0.45

0.33-0.60

0.48

0.38-0.62

Hispanic

0.91

0.60-1.37

0.39

0.26-0.57

0.67

0.49-0.94

Asian/Pacific

1.03

0.68-1.55

0.55

0.37-0.82

1.02

0.69-1.51

Native American

0.36

0.094-1.39

0.27

0.10-0.74

N/A

N/A

Other

1.14

0.70-1.88

0.52

0.33-0.82

0.59

0.38-0.93

Payer type (private
insurance)
Self-pay

<0.001
2.70

1.90-3.82

Medicaid

3.2

Medicare

1.83

No charge
Other

<0.001

<0.001

4.70

3.38-6.53

1.80

1.43-2.27

2.71-3.78

3.9

3.38-4.51

6.43

3.53-11.7

1.61-2.08

2.18

1.94-2.45

1.88

1.69-2.09

6.53

3.25-13.1

3.51

1.60-7.72

3.71

3.26-4.21

2.16

1.66-2.82

1.37

1.10-1.71

5.38

3.84-7.54

Household income
status (high income)

<0.001

<0.001

<0.001

Low income

2.33

1.64-3.30

1.40

1.01-1.95

1.75

1.33-2.31

Low/middle income

1.83

1.26-2.66

1.20

0.84-1.72

1.40

1.02-1.92

High/middle income

1.45

1.00-2.12

0.72

0.51-1.01

1.33

0.99-1.80

Hospital
location/teaching
status
(urban/teaching)

<0.001

<0.001

<0.001

Rural

3.02

1.18-7.70

7.56

1.78-32.15

12.1

3.79-38.4

Urban nonteaching

1.28

0.96-1.69

1.41

1.11-1.81

1.25

0.99-1.57
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Pvalue
<0.001

Table 10 cont. Complex Samples Multiple Logistic Regression for Individual Years in the
United States
2011
Variable (reference
group)

OR

2012
C.I

Age (40-49 years old)

Pvalue

2013

OR

C.I

<0.001

18-29 years old

1.08

30-39 years old

1.18

50-59 years old

1.35

60-69 years old

1.83

70-79 years old

4.62

80-90 years old

38.7

0.811.45
1.051.34
1.251.47
1.662.01
3.955.42
24.760.7

Race (African
American)
0.78

Hispanic

0.93

Asian/Pacific

1.1

Native American

1.4

Other

0.75

0.630.96
0.681.28
0.771.57
0.306.46
0.511.11

Payer type (private
insurance)
7.54

Medicaid

3.01

Medicare

1.83

No charge

2.93

Other

1.67

5.0811.2
2.673.38
1.652.02
1.535.64
1.372.04

Household income
status (high income)
2.39

Low/middle income

1.47

High/middle income

1.38

1.863.08
1.121.95
1.061.79

Hospital
location/teaching
status
(urban/teaching)

1.21

0.88-1.66

1.12

0.99-1.27

1.11

0.97-1.26

1.40

1.29-1.53

1.32

1.21-1.45

1.81

1.64-2.00

1.68

1.52-1.87

4.05

3.44-4.77

3.00

2.55-3.55

31.9

20.5-49.7

34.6

20.9-57.2

<0.001

10.22

Urban nonteaching

1.52

3.1233.53
1.241.87

<0.001

0.55

0.43-0.70

0.83

0.65-1.05

0.73

0.52-1.04

1.04

0.74-1.47

1.38

0.97-1.98

1.36

0.97-1.89

1.64

0.58-4.61

6.84

0.83-56.1

0.52

0.37-0.73

0.91

0.62-1.34

<0.001
3.61

2.77-4.71

4.59

3.37-6.24

2.81

2.52-3.14

2.56

2.29-2.87

2.04

1.84-2.26

2.19

1.97-2.44

3.27

1.71-6.24

3.63

1.97-6.68

1.82

1.47-2.24

1.37

1.11-1.69

0.10

<0.001

1.38

1.05-1.82

1.91

1.46-2.51

1.27

0.94-1.71

1.75

1.30-2.35

0.94

0.70-1.26

1.48

1.10-1.99

<0.001

Rural

Pvalue
<0.001

0.73-1.37

<0.001

Low income

C.I

1.00

<0.001

Self-pay

OR

<0.001

0.02
White

Pvalue

<0.001

<0.001

7.85

2.55-24.2

27.7

4.13-186

1.29

1.04-1.59

1.65

1.31-2.07
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Table 16. Individual Independent Variables Logistic Regression for Nevada
Variable (reference group)
Age (41-64 years old)
18-40 years old
65-90 years old
Race (nonwhite)
White

OR

C.I

P-value

0.47
3.30

0.37-0.60
2.70-4.03

1.45

1.20-1.75

<0.001

<0.001

Payer type (private insurance)
Self-pay
Medicaid
Medicare
Other

<0.001
6.49
4.98
5.13
2.65

3.05-13.9
3.27-7.58
4.18-6.29
1.56-4.52

Household income status (high
income)
Low income
Low/middle income
High/middle income

<0.001
2.14
1.54
1.13

1.62-2.84
1.23-1.92
0.94-1.36
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Appendix B: Healthcare Cost and Utilization Project Certification
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Appendix C: Internal Review Board Exclusion
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